pipette
ENEnglish

Variable penetrance of schizophrenia in 22q11.2 deletion syndrome is associated with impaired, but reversible, neuronal mitophagy.

E. Stronati, A. J. Rossano, J. Li, A. R. Stoesser, D. C. Wallace, C. Giulivi, S. A. Anderson

PreprintAfirmaciones fuertes, leer con cuidado

En palabras de los autores

The 22q11.2 deletion syndrome (22qDS) is a major genetic risk factor for schizophrenia (Sz). We found that iPSC-derived neurons (iNeurons) from 22qDS +Sz individuals exhibit weaker mitochondrial energetics, whereas iNeurons from individuals with the same deletion but no psychosis (22qDS -Sz) upregulate expression of mitochondrial biogenesis-related genes. Here, we investigated why the +Sz group fails to undergo this compensation, finding that 22qDS +Sz iNeurons have older and more depolarized mitochondria than 22qDS -Sz or controls. Transcriptomic and proteomic analyses revealed downregulation of mitophagy-related pathways, and live imaging revealed elevated lysosomal pH. Restoring lysosomal acidity with acidifying nanoparticles improved mitophagy and, remarkably, increased the expression of mitochondrial biogenesis-related transcription factors in the +Sz neurons. We conclude that lysosomal dysfunction and impaired mitophagy differentiate 22qDS individuals who develop schizophrenia from those who do not. Mitophagy could be a novel therapeutic or preventative opportunity for Sz in the context of genetic neurodevelopmental disorders.

Resultado principalEl resumen no menciona limitaciones.

Apareció: martes, 17 de noviembre. bioRxiv. Preprint, todavía sin revisión por pares.

DOI: 10.64898/2026.11.13.766189